NEW YORK, Feb. 3, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

https://static.prnasia.com/pro/fec/jwplayer-7.12.1/jwplayer.js jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”   NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer jwplayer(‘myplayer1’).setup({file: ‘https://mma.prnasia.com/media2/2875962/NYSE_Market_Update_Feb_3.mp4’, image: ‘https://mma.prnasia.com/media2/2875962/NYSE_Market_Update_Feb_3.mp4?p=thumbnail’, autostart:’false’, stretching : ‘uniform’, width: ‘512’, height: ‘288’});

Ashley Mastronardi delivers the pre-market update on February 3rd

Stocks are mixed as investors track a heavy week of corporate earnings — including reports from NYSE‑listed Pfizer, Eaton, Uber, and Eli Lilly — while labor data is disrupted by the postponement of Friday’s January Jobs Report due to the partial government shutdown. With government data delayed, market attention is shifting to private‑sector indicators and corporate outlooks to gauge the strength of the U.S. economy. NYSE-listed AstraZeneca scored a winning debut on the NYSE during Monday’s session, climbing 0.7%. The firm began trading on the exchange, marking the largest company transfer by market capitalization in NYSE history.

Opening BellOracle Corporation (NYSE: ORCL) rings the Opening Bell

Closing BellTyler Technologies (NYSE: TYL) celebrates its 60th birthday

Click here to check out Industry’s time at the NYSE

 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Yingjisha 500 MW Photovoltaic Sand Control Project Successfully Connected to the Grid and Commenced Operations

KASHGAR, China, April 14, 2025 /PRNewswire/ — On April 10, the first…

Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board

RB042 Phase 1 trial advances into multiple ascending dose study cohorts, demonstrating…

Alimentaria+Hostelco strengthens its international leadership with a 41% increase in global offerings

BARCELONA, Spain, Dec. 2, 2025 /PRNewswire/ — Alimentaria+Hostelco, the leading international platform…